abemaciclib
Showing 1 - 25 of 137
Meningioma Trial in Phoenix (Abemaciclib, Placebo)
Not yet recruiting
- Meningioma
- Abemaciclib
- Placebo
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Jul 4, 2023
Luminal Metastatic breAst caNcer in Real-life Clinical pracTice
Completed
- HR+/HER2- Breast Cancer
- +2 more
- Abemaciclib
-
Moscow, Russian FederationRussian Society of Clinical Oncology
Mar 29, 2023
Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)
Not yet recruiting
- Low Grade Serous Ovarian Carcinoma
- Adult Type Granulosa Cell Tumor
- Abemaciclib
- Letrozole
-
Gent, Oost-Vlaanderen, Belgium
- +2 more
May 12, 2023
Retroperitoneal Sarcoma Trial in Seattle (drug, procedure, radiation)
Not yet recruiting
- Retroperitoneal Sarcoma
- Abemaciclib
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 5, 2023
Kaposi Sarcoma Trial run by the NCI (Abemaciclib)
Recruiting
- Kaposi Sarcoma
- Abemaciclib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)
Recruiting
- Neurofibromatosis 1
- Abemaciclib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Hepatocellular Carcinoma Trial in Philadelphia (Abemaciclib, Nivolumab)
Terminated
- Hepatocellular Carcinoma
- Abemaciclib
- Nivolumab
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 17, 2022
Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)
Withdrawn
- Solid Tumor
- Advanced Breast Cancer
- Abemaciclib
- +6 more
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022
Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,
Not yet recruiting
- Breast Cancer
- +2 more
- Abemaciclib
- +5 more
-
Boston, Massachusetts
- +7 more
Aug 14, 2023
Cancer Trial in Boston (Abemaciclib)
Recruiting
- Cancer
- Abemaciclib
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)
Active, not recruiting
- Malignant Neoplasms of Female Genital Organs
- Fulvestrant
- Abemaciclib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
Breast Cancer Trial in Boston (Abemaciclib)
Terminated
- Breast Cancer
- Abemaciclib
-
Boston, MassachusettsDana-Farber Cancer Institute
Oct 3, 2022
Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)
Recruiting
- Cancer
- +6 more
- Abemaciclib
- LY3214996
-
Indianapolis, IndianaIndiana University Hospital / IU Simon Cancer Center
Jan 12, 2023
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Abemaciclib, Atezolizumab)
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- Abemaciclib
- Atezolizumab
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 26, 2022
Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)
Not yet recruiting
- Prostatic Neoplasms
- Abemaciclib
- +2 more
-
Mineola, New York
- +14 more
Aug 23, 2023
Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)
Active, not recruiting
- Sarcoma
- Dedifferentiated Liposarcoma
- Abemaciclib
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 17, 2022
Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A
Not yet recruiting
- Metastatic Prostate Cancer
- +2 more
- Darolutamide
- +4 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 14, 2022
Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)
Active, not recruiting
- Thyroid Cancer
- +2 more
- Abemaciclib
-
Stanford, CaliforniaStanford University
Nov 8, 2022
Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)
Recruiting
- Breast Neoplasms
- +7 more
- Elacestrant
- Abemaciclib
-
Canton, OhioGabrail Cancer Center
Jan 24, 2023
Glioblastoma Trial in United States (Abemaciclib, Surgery)
Active, not recruiting
- Glioblastoma
- Abemaciclib
- Surgery
-
Los Angeles, California
- +6 more
Dec 28, 2022
Brain Metastases, HR+ Metastatic Breast Cancer Trial in Tampa (Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy)
Recruiting
- Brain Metastases
- HR+ Metastatic Breast Cancer
- Stereotactic Radiosurgery (SRS)
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 1, 2022
Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)
Recruiting
- Myelofibrosis Due to and Following Polycythemia Vera
- Ruxolitinib
- Abemaciclib
-
Basking Ridge, New Jersey
- +6 more
Jan 26, 2023
Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)
Recruiting
- Clear Cell Renal Cell Carcinoma
- Abemaciclib
- MK-6482
-
Boston, Massachusetts
- +1 more
Dec 14, 2022